Safety and Tolerability of a Bioconjugate Vaccine Against Shigella Flexneri 2a
Clinical trial NCT02388009 · COMPLETED
Trial details
- NCT number
- NCT02388009
- Sponsor
- LimmaTech Biologics AG
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2015-05-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.